[144] Revolution Medicines, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Revolution Medicines, Inc. (RVMD) reporting a proposed sale of 10,000 common shares acquired and to be sold on 09/02/2025 following an exercise of stock options. The broker listed is Morgan Stanley Smith Barney LLC and the aggregate market value of the shares at filing is $379,700.00. The filing states the issuer has 186,933,190 shares outstanding. The seller previously disposed of 2,170 common shares on 06/16/2025 for $86,431.10. The filer affirms no undisclosed material adverse information and includes standard Rule 10b5-1/attestation language.

Positive

• Transparent disclosure of the proposed sale, including broker, dates, and aggregate market value
• Compliance with Rule 144 and attestation regarding undisclosed material information
• Transaction clearly documented as an exercise of stock options with cash payment

Negative

• None.

Insights

Securities/Financial Analyst

TL;DR: Routine Rule 144 disclosure of an option exercise and proposed sale; not materially large relative to shares outstanding.

The Form 144 documents a 10,000-share sale tied to an option exercise on the same date, routed through Morgan Stanley Smith Barney LLC, with an aggregate market value of $379,700. Compared with the stated 186,933,190 shares outstanding, the position is immaterial in size and consistent with routine executive liquidity. The recent prior sale of 2,170 shares for $86,431.10 is also disclosed. This filing primarily reflects compliance with Rule 144 and public disclosure requirements rather than a material corporate development.

Corporate Governance Expert

TL;DR: Proper insider disclosure and attestation present; no immediate governance red flags in the filing.

The notice includes the required attestation that the seller is unaware of undisclosed material adverse information and documents transaction mechanics (option exercise, cash payment). The broker and dates are specified, and recent sales within three months are disclosed, showing adherence to disclosure protocols. There is no indication in this form of unusual trading patterns or governance concerns based solely on the provided data.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	379700.00	186933190	09/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/02/2025	Exercise of Stock Options	Issuer			10000	09/02/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JACK LEE ANDERS 700 Saginaw Drive Redwood City CA 94063	Common	06/16/2025	2170	86431.10

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for RVMD report?

The Form 144 reports a proposed sale of 10,000 common shares of RVMD acquired by exercise of stock options and to be sold on 09/02/2025 through Morgan Stanley Smith Barney LLC with an aggregate market value of $379,700.00.

How large is the 10,000-share sale relative to RVMD's outstanding shares?

The filing lists 186,933,190 shares outstanding, making the 10,000-share sale immaterial as a percentage of total shares outstanding.

Did the filer sell other RVMD shares recently?

Yes; the filing discloses a prior sale of 2,170 common shares on 06/16/2025 with gross proceeds of $86,431.10.

What was the method of acquisition for the shares being sold?

The 10,000 shares were acquired on 09/02/2025 by exercise of stock options from the issuer, with payment made in cash.

Which broker is handling the proposed sale?

The broker listed on the Form 144 is Morgan Stanley Smith Barney LLC, 1 New York Plaza, 8th Floor, New York, NY.